BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29462468)

  • 1. The impact of vitamin D status and parameters of calcium metabolism in patients with primary hyperparathyroidism.
    Tripto-Shkolnik L; Jaffe A; Liel Y
    QJM; 2018 Feb; 111(2):97-101. PubMed ID: 29462468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.
    Grey A; Lucas J; Horne A; Gamble G; Davidson JS; Reid IR
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2122-6. PubMed ID: 15644400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of vitamin D replacement in patients with normocalcaemic and hypercalcaemic primary hyperparathyroidism and coexisting vitamin D deficiency.
    Das G; Eligar V; Govindan J; Bondugulapati LN; Okosieme O; Davies S
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):462-9. PubMed ID: 25468998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
    Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data.
    Diamond TH; Ho KW; Rohl PG; Meerkin M
    Med J Aust; 2005 Jul; 183(1):10-2. PubMed ID: 15992330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculating an individual maxPTH to aid diagnosis of normocalemic primary hyperparathyroidism.
    Jin J; Mitchell J; Shin J; Berber E; Siperstein AE; Milas M
    Surgery; 2012 Dec; 152(6):1184-92. PubMed ID: 23102677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hypovitaminosis D in patients with primary hyperparathyroidism.
    Rathi MS; Gonzalez S; Wright D; Ellis NR; Peacey SR
    J Endocrinol Invest; 2014 May; 37(5):467-71. PubMed ID: 24515299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of vitamin D3 in adults with multiple sclerosis.
    Kimball SM; Ursell MR; O'Connor P; Vieth R
    Am J Clin Nutr; 2007 Sep; 86(3):645-51. PubMed ID: 17823429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholecalciferol supplementation improves secondary hyperparathyroidism control in hemodialysis patients].
    Massimetti C; Bellasi A; Feriozzi S
    G Ital Nefrol; 2020 Jun; 37(3):. PubMed ID: 32530156
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitamin D-binding protein levels do not influence the effect of vitamin D repletion on serum PTH and calcium: data from a randomized, controlled trial.
    Ponda MP; McGee D; Breslow JL
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2494-9. PubMed ID: 24712573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D.
    Tucci JR
    Eur J Endocrinol; 2009 Jul; 161(1):189-93. PubMed ID: 19383807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An oral high dose of cholecalciferol restores vitamin D status in deficient postmenopausal HIV-1-infected women independently of protease inhibitors therapy: a pilot study.
    Pepe J; Mezzaroma I; Fantauzzi A; Falciano M; Salotti A; Di Traglia M; Diacinti D; Biondi P; Cipriani C; Cilli M; Minisola S
    Endocrine; 2016 Jul; 53(1):299-304. PubMed ID: 26254790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels--an observational study during clinical practice conditions.
    Leidig-Bruckner G; Roth HJ; Bruckner T; Lorenz A; Raue F; Frank-Raue K
    Osteoporos Int; 2011 Jan; 22(1):231-40. PubMed ID: 20556359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation.
    Corey RL; Whitaker MD; Crowell MD; Keddis MT; Aqel B; Balan V; Byrne T; Carey E; Douglas DD; Harrison ME; Vargas HE; Rakela J
    Clin Transplant; 2014 May; 28(5):579-84. PubMed ID: 24628047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of vitamin D levels on postoperative calcium requirements, symptomatic hypocalcemia, and parathormone levels following parathyroidectomy for primary hyperparathyroidism.
    Press D; Politz D; Lopez J; Norman J
    Surgery; 2011 Dec; 150(6):1061-8. PubMed ID: 22136822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D deficiency and primary hyperparathyroidism.
    Silverberg SJ
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V100-4. PubMed ID: 18290710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association between preoperative cholecalciferol therapy and hypocalcemia after parathyroidectomy in patients with primary hyperparathyroidism].
    Elfimova AR; Eremkina AK; Rebrova OY; Kovaleva EV; Mokrysheva NG
    Probl Endokrinol (Mosk); 2024 Feb; 70(1):38-45. PubMed ID: 38433540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vitamin D metabolite and calcium phosphorus metabolism in in patients with primary hyperparathyroidism on the background of bolus therapy with colecalciferol].
    Maganeva IS; Pigarova EA; Shulpekova NV; Dzeranova LK; Eremkina AK; Miliutina AP; Povaliaeva AA; Zhukov AY; Bogdanov VP; Rozhinskaya LY; Mokrysheva NG
    Probl Endokrinol (Mosk); 2021 Dec; 67(6):68-79. PubMed ID: 35018763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.
    Untch BR; Barfield ME; Dar M; Dixit D; Leight GS; Olson JA
    Surgery; 2007 Dec; 142(6):1022-6. PubMed ID: 18063090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-supplementation of vitamin D in two patients with primary hyperparathyroidism.
    Battista C; Viti R; Minisola S; Chiodini I; Frusciante V; Scillitani A; Carnevale V
    Hormones (Athens); 2013; 12(4):598-601. PubMed ID: 24457409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.